These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

496 related items for PubMed ID: 19794071

  • 1. Costimulatory pathways in multiple sclerosis: distinctive expression of PD-1 and PD-L1 in patients with different patterns of disease.
    Trabattoni D, Saresella M, Pacei M, Marventano I, Mendozzi L, Rovaris M, Caputo D, Borelli M, Clerici M.
    J Immunol; 2009 Oct 15; 183(8):4984-93. PubMed ID: 19794071
    [Abstract] [Full Text] [Related]

  • 2. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B, Mitsdoerffer M, Kieseier BC, Chen L, Hartung HP, Weller M, Wiendl H.
    J Neuroimmunol; 2004 Oct 15; 155(1-2):172-82. PubMed ID: 15342209
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production.
    Chapoval AI, Ni J, Lau JS, Wilcox RA, Flies DB, Liu D, Dong H, Sica GL, Zhu G, Tamada K, Chen L.
    Nat Immunol; 2001 Mar 15; 2(3):269-74. PubMed ID: 11224528
    [Abstract] [Full Text] [Related]

  • 8. Contributions of PD-1/PD-L1 pathway to interactions of myeloid DCs with T cells in atherosclerosis.
    Lee J, Zhuang Y, Wei X, Shang F, Wang J, Zhang Y, Liu X, Yang Y, Liu L, Zheng Q.
    J Mol Cell Cardiol; 2009 Feb 15; 46(2):169-76. PubMed ID: 19056397
    [Abstract] [Full Text] [Related]

  • 9. Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B.
    Fisicaro P, Valdatta C, Massari M, Loggi E, Biasini E, Sacchelli L, Cavallo MC, Silini EM, Andreone P, Missale G, Ferrari C.
    Gastroenterology; 2010 Feb 15; 138(2):682-93, 693.e1-4. PubMed ID: 19800335
    [Abstract] [Full Text] [Related]

  • 10. Interferon-beta up-regulates the expression of co-stimulatory molecules CD80, CD86 and CD40 on monocytes: significance for treatment of multiple sclerosis.
    Marckmann S, Wiesemann E, Hilse R, Trebst C, Stangel M, Windhagen A.
    Clin Exp Immunol; 2004 Dec 15; 138(3):499-506. PubMed ID: 15544628
    [Abstract] [Full Text] [Related]

  • 11. B7-H1 restricts neuroantigen-specific T cell responses and confines inflammatory CNS damage: implications for the lesion pathogenesis of multiple sclerosis.
    Ortler S, Leder C, Mittelbronn M, Zozulya AL, Knolle PA, Chen L, Kroner A, Wiendl H.
    Eur J Immunol; 2008 Jun 15; 38(6):1734-44. PubMed ID: 18421793
    [Abstract] [Full Text] [Related]

  • 12. CD80 and CD86 expression on LPS-stimulated monocytes and the effect of CD80 and CD86 blockade on IL-4 and IFN-gamma production in nonatopic bronchial asthma.
    Rutkowski R, Moniuszko T, Stasiak-Barmuta A, Kosztyła-Hojna B, Alifier M, Rutkowski K, Tatarczuk-Krawiel A.
    Arch Immunol Ther Exp (Warsz); 2003 Jun 15; 51(6):421-8. PubMed ID: 14692664
    [Abstract] [Full Text] [Related]

  • 13. Synovium infiltrating T cells induce excessive synovial cell function through CD28/B7 pathway in patients with rheumatoid arthritis.
    Shimoyama Y, Nagafuchi H, Suzuki N, Ochi T, Sakane T.
    J Rheumatol; 1999 Oct 15; 26(10):2094-101. PubMed ID: 10529123
    [Abstract] [Full Text] [Related]

  • 14. CTLA4-CD80/CD86 interactions on primary mouse CD4+ T cells integrate signal-strength information to modulate activation with Concanavalin A.
    Mukherjee S, Ahmed A, Nandi D.
    J Leukoc Biol; 2005 Jul 15; 78(1):144-57. PubMed ID: 15788440
    [Abstract] [Full Text] [Related]

  • 15. The costimulatory signal upregulation is associated with Th1 bias at the maternal-fetal interface in human miscarriage.
    Jin LP, Fan DX, Zhang T, Guo PF, Li DJ.
    Am J Reprod Immunol; 2011 Oct 15; 66(4):270-8. PubMed ID: 21481059
    [Abstract] [Full Text] [Related]

  • 16. Modulation of cell cycle progression by CTLA4-CD80/CD86 interactions on CD4+ T cells depends on strength of the CD3 signal: critical role for IL-2.
    Mukherjee S, Ahmed A, Malu S, Nandi D.
    J Leukoc Biol; 2006 Jul 15; 80(1):66-74. PubMed ID: 16624934
    [Abstract] [Full Text] [Related]

  • 17. CD4+CD25+FoxP3+PD1- regulatory T cells in acute and stable relapsing-remitting multiple sclerosis and their modulation by therapy.
    Saresella M, Marventano I, Longhi R, Lissoni F, Trabattoni D, Mendozzi L, Caputo D, Clerici M.
    FASEB J; 2008 Oct 15; 22(10):3500-8. PubMed ID: 18587005
    [Abstract] [Full Text] [Related]

  • 18. PD-L1 partially protects renal tubular epithelial cells from the attack of CD8+ cytotoxic T cells.
    Waeckerle-Men Y, Starke A, Wüthrich RP.
    Nephrol Dial Transplant; 2007 Jun 15; 22(6):1527-36. PubMed ID: 17339272
    [Abstract] [Full Text] [Related]

  • 19. Intrahepatic expression of the co-stimulatory molecules programmed death-1, and its ligands in autoimmune liver disease.
    Oikawa T, Takahashi H, Ishikawa T, Hokari A, Otsuki N, Azuma M, Zeniya M, Tajiri H.
    Pathol Int; 2007 Aug 15; 57(8):485-92. PubMed ID: 17610472
    [Abstract] [Full Text] [Related]

  • 20. Augmented type 1 cytokines and human endogenous retroviruses specific immune responses in patients with acute multiple sclerosis.
    Trabattoni D, Ferrante P, Fusi ML, Saresella M, Caputo D, Urnovitz H, Cazzullo CL, Clerici M.
    J Neurovirol; 2000 May 15; 6 Suppl 2():S38-41. PubMed ID: 10871783
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.